Akebia Therapeutics (AKBA) Ownership - Who owns Akebia Therapeutics?

Industry: @Biotechnology
17 days until earnings call

Profile

Industry
Biotechnology
Address
245 First Street
Phone
+1 617 871-2098
Employees
167
Web
https://www.akebia.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
264.09M
P/E Ratio
N/A
Total Cash
41.96M
Projected Growth
N/A
Total Debt
42.85M
Revenue
187.23M
Risk (Beta)
0.22
Dividend Yield
N/A
Total Cash/Share
0.20
Total Debt/Equity
N/A
Revenue/Share
0.97 USD as % of share price

Fundamentals

AKBA
Capitalization
264M
P/E Ratio
N/A
Risk (Beta)
0.22
Dividend Yield
N/A
Total Cash
42M
Total Cash/Share
0.20
Total Debt
42.9M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.97%
Revenue
187M
ROE
N/A
Book Value
-27.26M
P/B Ratio
N/A
Cash Flow
N/A
Earnings
-0.22
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
2K
Current Ratio
1.70
Current Revenue Per Employee
195251.50
Dividends Per Share - Security
N/A
EBITDA
1.53M
Float
N/A
Float - Current
N/A
Gross Income Margin
64.41
Revenue To Assets
-17.13
Shares Held By Institutions
121M
Shares Outstanding - Current
210M
Total Liabilities
253M
Total Volume MTD
N/A
Value
-1
Gain YTD
1.613
View a ticker or compare two or three
AKBA
Daily Signal changed days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of drugs for the treatment of anemia and vascular diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
245 First Street
Phone
+1 617 871-2098
Employees
167
Web
https://www.akebia.com